1. Adipocyte‐Derived Exosomal MTTP Suppresses Ferroptosis and Promotes Chemoresistance in Colorectal Cancer. Issue 28 (17th August 2022) Authors: Zhang, Qiumo; Deng, Ting; Zhang, Hongdian; Zuo, Duo; Zhu, Qihang; Bai, Ming; Liu, Rui; Ning, Tao; Zhang, Le; Yu, Zhentao; Zhang, Haiyang; Ba, Yi Journal: Advanced science Issue: Volume 9:Issue 28(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Aflibercept plus FOLFIRI in Asian patients with pretreated metastatic colorectal cancer: a randomized Phase III study. (17th August 2018) Authors: Li, Jin; Xu, Ruihua; Qin, Shukui; Liu, Tianshu; Pan, Hongming; Xu, Jianming; Bi, Feng; Lim, Robert; Zhang, Suzhan; Ba, Yi; Bai, Yuxian; Fan, Nanfeng; Tsuji, Akihito; Yeh, Kun-Huei; Ma, Brigette; Wei, Vivian; Shi, Dongmei; Magherini, Emmanuelle; Shen, Lin Journal: Future oncology Issue: Volume 14:Number 20(2018) Page Start: 2031 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Anlotinib for previously treated advanced or metastatic esophageal squamous cell carcinoma: A double‐blind randomized phase 2 trial. (14th February 2021) Authors: Huang, Jing; Xiao, Juxiang; Fang, Wentao; Lu, Ping; Fan, Qingxia; Shu, Yongqian; Feng, Jifeng; Zhang, Shu; Ba, Yi; Zhao, Yang; Liu, Ying; Bai, Chunmei; Bai, Yuxian; Tang, Yong; Song, Yan; He, Jie Journal: Cancer medicine Issue: Volume 10:Number 5(2021) Page Start: 1681 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Anlotinib Monotherapy for Refractory Metastatic Colorectal Cancer: A Double-Blinded, Placebo-Controlled, Randomized Phase III Trial (ALTER0703). (25th June 2021) Authors: Chi, Yihebali; Shu, Yongqian; Ba, Yi; Bai, Yuxian; Qin, Baoli; Wang, Xiuwen; Xiong, Jianping; Xu, Nong; Zhang, Helong; Zhou, Jianfeng; Xu, Jianming; Cheng, Ying; Feng, Jifeng; Hu, Chunhong; Chen, Yigui; Chen, Zhendong; Wang, Jufeng; Dang, Chengxue; Wang, Jianhong; Wan, Yiye Journal: Oncologist Issue: Volume 26:Number 10(2021) Page Start: e1693 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Anlotinib Monotherapy for Refractory Metastatic Colorectal Cancer: A Double‐Blinded, Placebo‐Controlled, Randomized Phase III Trial (ALTER0703). (25th June 2021) Authors: Chi, Yihebali; Shu, Yongqian; Ba, Yi; Bai, Yuxian; Qin, Baoli; Wang, Xiuwen; Xiong, Jianping; Xu, Nong; Zhang, Helong; Zhou, Jianfeng; Xu, Jianming; Cheng, Ying; Feng, Jifeng; Hu, Chunhong; Chen, Yigui; Chen, Zhendong; Wang, Jufeng; Dang, Chengxue; Wang, Jianhong; Wan, Yiye Journal: Oncologist Issue: Volume 26:Number 10(2021) Page Start: e1693 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Camrelizumab versus investigator's choice of chemotherapy as second-line therapy for advanced or metastatic oesophageal squamous cell carcinoma (ESCORT): a multicentre, randomised, open-label, phase 3 study. Issue 6 (June 2020) Authors: Huang, Jing; Xu, Jianming; Chen, Yun; Zhuang, Wu; Zhang, Yiping; Chen, Zhendong; Chen, Jia; Zhang, Helong; Niu, Zuoxing; Fan, Qingxia; Lin, Lizhu; Gu, Kangsheng; Liu, Ying; Ba, Yi; Miao, Zhanhui; Jiang, Xiaodong; Zeng, Ming; Chen, Jianhua; Fu, Zhichao; Gan, Lu Journal: Lancet oncology Issue: Volume 21:Issue 6(2020) Page Start: 832 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Cell-derived microvesicles mediate the delivery of miR-29a/c to suppress angiogenesis in gastric carcinoma. Issue 2 (1st June 2016) Authors: Zhang, Haiyang; Bai, Ming; Deng, Ting; Liu, Rui; Wang, Xia; Qu, Yanjun; Duan, Jingjing; Zhang, Le; Ning, Tao; Ge, Shaohua; Li, Hongli; Zhou, Likun; Liu, Yuchen; Huang, Dingzhi; Ying, Guoguang; Ba, Yi Journal: Cancer letters Issue: Volume 375:Issue 2(2016) Page Start: 331 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Challenges in anticancer drug R&D in China. Issue 2 (February 2019) Authors: Zhao, Shen; Lv, Cheng; Gong, Jifang; Wenfeng, Fang; Hu, Xichun; Ba, Yi; Xiaoyuan, Chen; Zhimin, Yang; Shen, Lin; Zhang, Li Journal: Lancet oncology Issue: Volume 20:Issue 2(2019) Page Start: 183 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Chinese expert recommendations on management of hepatocellular carcinoma during COVID-19 pandemic: a nationwide multicenter survey. Issue 3 (March 2022) Authors: Zhao, Hong; Zhou, Aiping; Zhou, Jianguo; Bi, Xinyu; Yan, Shida; Jin, Jing; Wei, Wenqiang; Li, Muxing; Gong, Caifeng; Chen, Qichen; Luo, Zhiwen; Li, Ning; Mao, Rui; Chen, Xiao; Chen, Bo; Zheng, Rongshou; Zhao, Jianjun; Han, Yue; Li, Zhiyu; Che, Xu Journal: HPB Issue: Volume 24:Issue 3(2022) Page Start: 342 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Classification Tree–Based Machine Learning to Visualize and Validate a Decision Tool for Identifying Malnutrition in Cancer Patients. Issue 8 (15th March 2021) Authors: Yin, Liangyu; Lin, Xin; Liu, Jie; Li, Na; He, Xiumei; Zhang, Mengyuan; Guo, Jing; Yang, Jian; Deng, Li; Wang, Yizhuo; Liang, Tingting; Wang, Chang; Jiang, Hua; Fu, Zhenming; Li, Suyi; Wang, Kunhua; Guo, Zengqing; Ba, Yi; Li, Wei; Song, Chunhua Journal: JPEN, Journal of parenteral and enteral nutrition Issue: Volume 45:Issue 8(2021) Page Start: 1736 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗